These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 10543427)
1. Hypericum perforatum L. extract does not inhibit 5-HT transporter in rat brain cortex. Gobbi M; Valle FD; Ciapparelli C; Diomede L; Morazzoni P; Verotta L; Caccia S; Cervo L; Mennini T Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):262-9. PubMed ID: 10543427 [TBL] [Abstract][Full Text] [Related]
2. In vitro binding studies with two hypericum perforatum extracts--hyperforin, hypericin and biapigenin--on 5-HT6, 5-HT7, GABA(A)/benzodiazepine, sigma, NPY-Y1/Y2 receptors and dopamine transporters. Gobbi M; Moia M; Pirona L; Morizzoni P; Mennini T Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S45-8. PubMed ID: 11518075 [TBL] [Abstract][Full Text] [Related]
3. Acute and chronic actions of a dry methanolic extract of Hypericum perforatum and a hyperforin-rich extract on dopaminergic and serotonergic neurones in rat nucleus accumbens. Rommelspacher H; Siemanowitz B; Mannel M Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S119-26. PubMed ID: 11518060 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of vesicular uptake of monoamines by hyperforin. Roz N; Mazur Y; Hirshfeld A; Rehavi M Life Sci; 2002 Sep; 71(19):2227-37. PubMed ID: 12215370 [TBL] [Abstract][Full Text] [Related]
5. The serotonergic antidepressant nefazodone inhibits the serotonin transporter: in vivo and ex vivo studies. Owens MJ; Ieni JR; Knight DL; Winders K; Nemeroff CB Life Sci; 1995; 57(24):PL373-80. PubMed ID: 7475971 [TBL] [Abstract][Full Text] [Related]
6. Effect of acute administration of hypericum perforatum-CO2 extract on dopamine and serotonin release in the rat central nervous system. Di Matteo V; Di Giovanni G; Di Mascio M; Esposito E Pharmacopsychiatry; 2000 Jan; 33(1):14-8. PubMed ID: 10721879 [TBL] [Abstract][Full Text] [Related]
7. Evidence for presynaptic location of inhibitory 5-HT1D beta-like autoreceptors in the guinea-pig brain cortex. Bühlen M; Fink K; Böing C; Göthert M Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):281-9. PubMed ID: 8692282 [TBL] [Abstract][Full Text] [Related]
8. Effects of Hypericum perforatum (St. John's wort) on passive avoidance in the rat: evaluation of potential neurochemical mechanisms underlying its antidepressant activity. Misane I; Ogren SO Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S89-97. PubMed ID: 11518084 [TBL] [Abstract][Full Text] [Related]
10. In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist properties. Pullar IA; Boot JR; Carney SL; Cohen ML; Colvin EM; Conway RG; Hardy CH; Lucaites VL; Nelson DL; Schenck KW; Tomlinson R; Wedley S Eur J Pharmacol; 2001 Nov; 432(1):9-17. PubMed ID: 11734182 [TBL] [Abstract][Full Text] [Related]
11. LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine(2A) receptor antagonist: a comparison with the antidepressant, nefazodone. Pullar IA; Carney SL; Colvin EM; Lucaites VL; Nelson DL; Wedley S Eur J Pharmacol; 2000 Oct; 407(1-2):39-46. PubMed ID: 11050288 [TBL] [Abstract][Full Text] [Related]
12. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract. Müller WE; Singer A; Wonnemann M; Hafner U; Rolli M; Schäfer C Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():16-21. PubMed ID: 9684943 [TBL] [Abstract][Full Text] [Related]
13. St. John's wort extract Ze 117 (Hypericum perforatum) inhibits norepinephrine and serotonin uptake into rat brain slices and reduces 3-adrenoceptor numbers on cultured rat brain cells. Kientsch U; Bürgi S; Ruedeberg C; Probst S; Honegger UE Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S56-60. PubMed ID: 11518078 [TBL] [Abstract][Full Text] [Related]
14. Inhibition by nitric oxide of the uptake of [3H]serotonin into rat brain synaptosomes. Asano S; Matsuda T; Nakasu Y; Maeda S; Nogi H; Baba A Jpn J Pharmacol; 1997 Oct; 75(2):123-8. PubMed ID: 9414026 [TBL] [Abstract][Full Text] [Related]
15. Hyperforin as a possible antidepressant component of hypericum extracts. Chatterjee SS; Bhattacharya SK; Wonnemann M; Singer A; Müller WE Life Sci; 1998; 63(6):499-510. PubMed ID: 9718074 [TBL] [Abstract][Full Text] [Related]
16. Serotonin, norepinephrine and dopamine involvement in the antidepressant action of hypericum perforatum. Calapai G; Crupi A; Firenzuoli F; Inferrera G; Squadrito F; Parisi A; De Sarro G; Caputi A Pharmacopsychiatry; 2001 Mar; 34(2):45-9. PubMed ID: 11302563 [TBL] [Abstract][Full Text] [Related]
17. Effects of oral administration of extracts of Hypericum perforatum (St John's wort) on brain serotonin transporter, serotonin uptake and behaviour in mice. Hirano K; Kato Y; Uchida S; Sugimoto Y; Yamada J; Umegaki K; Yamada S J Pharm Pharmacol; 2004 Dec; 56(12):1589-95. PubMed ID: 15563766 [TBL] [Abstract][Full Text] [Related]
18. Adhyperforin as a contributor to the effect of Hypericum perforatum L. in biochemical models of antidepressant activity. Jensen AG; Hansen SH; Nielsen EO Life Sci; 2001 Feb; 68(14):1593-605. PubMed ID: 11263672 [TBL] [Abstract][Full Text] [Related]
19. 1-(m-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain. Baumann MH; Ayestas MA; Dersch CM; Rothman RB Neuropsychopharmacology; 2001 May; 24(5):492-501. PubMed ID: 11282249 [TBL] [Abstract][Full Text] [Related]
20. Hypericum perforatum L. (St John's wort) extract Ze 117 inhibits dopamine re-uptake in rat striatal brain slices. An implication for use in smoking cessation treatment? Ruedeberg C; Wiesmann UN; Brattstroem A; Honegger UE Phytother Res; 2010 Feb; 24(2):249-51. PubMed ID: 19585471 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]